WO1998042312A3 - Medicament having sclerosing activity - Google Patents

Medicament having sclerosing activity Download PDF

Info

Publication number
WO1998042312A3
WO1998042312A3 PCT/EP1998/001699 EP9801699W WO9842312A3 WO 1998042312 A3 WO1998042312 A3 WO 1998042312A3 EP 9801699 W EP9801699 W EP 9801699W WO 9842312 A3 WO9842312 A3 WO 9842312A3
Authority
WO
WIPO (PCT)
Prior art keywords
medicament
sclerosing
activity
solution
sclerosing activity
Prior art date
Application number
PCT/EP1998/001699
Other languages
French (fr)
Other versions
WO1998042312A2 (en
Inventor
Marcello Izzo
Gianfranco Verzella
Original Assignee
I V Pharma S A S
Marcello Izzo
Gianfranco Verzella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I V Pharma S A S, Marcello Izzo, Gianfranco Verzella filed Critical I V Pharma S A S
Priority to EP98920482A priority Critical patent/EP0971697A2/en
Publication of WO1998042312A2 publication Critical patent/WO1998042312A2/en
Publication of WO1998042312A3 publication Critical patent/WO1998042312A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention relates to the use of a solution of a soluble, pharmaceutically acceptable salt of salicylic acid, said solution having a pH between 7.0 (+/-1) and 9.0 (+/-1), as active ingredient for the preparation of a medicament having sclerosing activity useful for the treatment of varixes.
PCT/EP1998/001699 1997-03-25 1998-03-23 Medicament having sclerosing activity WO1998042312A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP98920482A EP0971697A2 (en) 1997-03-25 1998-03-23 Medicament having sclerosing activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI970700 IT1290439B1 (en) 1997-03-25 1997-03-25 DRESSING WITH SCLEROSANT ACTIVITY
ITMI97A000700 1997-03-25

Publications (2)

Publication Number Publication Date
WO1998042312A2 WO1998042312A2 (en) 1998-10-01
WO1998042312A3 true WO1998042312A3 (en) 1998-11-05

Family

ID=11376623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/001699 WO1998042312A2 (en) 1997-03-25 1998-03-23 Medicament having sclerosing activity

Country Status (3)

Country Link
EP (1) EP0971697A2 (en)
IT (1) IT1290439B1 (en)
WO (1) WO1998042312A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2216708B1 (en) * 2003-04-08 2006-02-16 Antonio Luis Cabrera Garrido "AWESOME SOLUTION".

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321119A (en) * 1979-11-07 1982-03-23 Gelman Sciences, Inc. Buffer composition and method for the electrophoretic separation of proteins
EP0572963A2 (en) * 1992-06-02 1993-12-08 Sergio Capurro High efficacy sclerosing solution causing no iatrogenic lesions and process to obtain this solution
EP0838225A2 (en) * 1996-10-25 1998-04-29 Hiji, Yasutake Aqueous local anesthetic solution

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321119A (en) * 1979-11-07 1982-03-23 Gelman Sciences, Inc. Buffer composition and method for the electrophoretic separation of proteins
EP0572963A2 (en) * 1992-06-02 1993-12-08 Sergio Capurro High efficacy sclerosing solution causing no iatrogenic lesions and process to obtain this solution
EP0838225A2 (en) * 1996-10-25 1998-04-29 Hiji, Yasutake Aqueous local anesthetic solution

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Vidal 1996", 1996, EDITIONS DU VIDAL, PARIS, XP002076036 *
BULZOMI G. ET AL: "Sclerosing treatment of varices of the lower limbs: results with aethoxysclerol and sodium salicylate", ACTA CHIR. ITAL., vol. 46, no. 3, 1990, pages 287 - 290, XP002076035 *
GRITON P.: "Actualité du salicylate", PHLEBOLOGIE, vol. 31, no. 2, 1978, pages 89 - 92, XP002076034 *

Also Published As

Publication number Publication date
IT1290439B1 (en) 1998-12-03
ITMI970700A1 (en) 1998-09-25
WO1998042312A2 (en) 1998-10-01
EP0971697A2 (en) 2000-01-19

Similar Documents

Publication Publication Date Title
CA2386690A1 (en) Pharmaceutical tramadol salts
CA2468916A1 (en) A stable oxaliplatin solution formulation
CA2123160A1 (en) Controlled release formulation
PL338415A1 (en) Application of physiologically compatible vanadium compounds, salts and complexes
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
EP1426360A4 (en) 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
CA2420640A1 (en) Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients
EP1550667A4 (en) Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same
CA2394471A1 (en) External preparation for treating pruritus
WO1998042312A3 (en) Medicament having sclerosing activity
ZA200006081B (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-A/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
ZA975755B (en) Useful formulations of acid addition salt drugs.
BG106151A (en) Pharmaceutical complex
CA2320627A1 (en) Medicament for treatment of diastolic dysfunction
HK1041000A1 (en) Novel pyrimidine derivatives and processes for thepreparation thereof.
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms
IE840977L (en) Pharmaceutical preparations
ATE234096T1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION CONTAINING THE ACTIVE INGREDIENT MORPHINE-6-GLUCURONIDE
WO2002006299A3 (en) Therapeutic uses for aminosterol compounds
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
HUP0103623A3 (en) Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): BR CA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998920482

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998920482

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998920482

Country of ref document: EP